Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes

Adv Enzyme Regul. 2008:48:2-9. doi: 10.1016/j.advenzreg.2007.11.013. Epub 2008 Mar 17.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Azacitidine / pharmacology
  • Cell Differentiation / drug effects
  • Humans
  • Myelodysplastic Syndromes / drug therapy
  • Myelodysplastic Syndromes / physiopathology*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphatidylinositols / physiology*
  • Phospholipase C beta / genetics
  • Phospholipase C beta / physiology
  • Protein Kinases / physiology
  • Proto-Oncogene Proteins c-akt / physiology
  • Signal Transduction / physiology*
  • TOR Serine-Threonine Kinases

Substances

  • Phosphatidylinositols
  • Protein Kinases
  • MTOR protein, human
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Phospholipase C beta
  • Azacitidine